INDIANAPOLIS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and global access to life-changing ...
BEDFORD, Mass., and INDIANAPOLIS, Dec. 18, 2023 (GLOBE NEWSWIRE) -- December 18, 2023 – Lantheus Holdings, Inc. (LNTH) (Lantheus) and POINT Biopharma Global Inc. (POINT) (NASDAQ: PNT) today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback